N-CYCLOPROPYL-4-METHYL-3-(2-((2-(4-MORPHOLINYL)ETHYL)AMINO)-6-QUINAZOLINYL)BENZAMIDE
UNII NB996YN9AQ
Substance Identification & Data
This profile provides standardized clinical and technical data for N-cyclopropyl-4-methyl-3-(2-((2-(4-morpholinyl)ethyl)amino)-6-quinazolinyl)benzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NB996YN9AQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 882664-10-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H29N5O2 MNEXDVSJIUQQRH-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-cyclopropyl-4-methyl-3-(2-((2-(4-morpholinyl)ethyl)amino)-6-quinazolinyl)benzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.